Triple
T2190710
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Darzalex |
E49853
|
entity |
| Predicate | usedInCombinationWith |
P4791
|
FINISHED |
| Object |
bortezomib
Bortezomib is a proteasome inhibitor chemotherapy drug primarily used in the treatment of multiple myeloma and certain types of lymphoma.
|
E241388
|
NE FINISHED |
Provenance (5 batches)
| Stage | Batch ID | Job type | Status |
|---|---|---|---|
| creating | batch_69a88aaba3c48190b351cab9b26989ff |
elicitation | completed |
| NER | batch_69abc5b101d48190a321625720d537b6 |
ner | completed |
| NED1 | batch_69ae5db0352c8190aa9c4c58460df3a4 |
ned_source_triple | completed |
| NED2 | batch_69ae5ec4a35c8190bffc7a183497e764 |
ned_description | completed |
| NEDg | batch_69ae5e60b45c819088bf18ae564f0d1a |
nedg | completed |
Created at: March 4, 2026, 7:46 p.m.